HEXPOL (HPOL) CMD 2025 summary
Event summary combining transcript, slides, and related documents.
CMD 2025 summary
11 Mar, 2026Strategic Direction and Growth Plans
Targeting organic and M&A-driven growth, aiming for a 10%+ EPS CAGR from 2026–2030, more than double the previous decade's rate.
Focused on expanding in thermoplastic compounding, engineered products, and selected Asian markets, with a strong push for cross-selling and portfolio expansion.
Prioritizing high-margin segments in engineered and high-performance polymers, while selectively targeting profitable opportunities in commodity polymers.
Strengthening R&D to drive innovation and sustainability, with increased emphasis on research, new product development, and automation.
Decentralized structure and local presence to enhance customer proximity and operational agility.
Financial Guidance and Targets
New financial targets: EPS CAGR above 10% (2026–2030), net debt/EBITDA below 2.5, and dividend payout of 40%-60% of net profits.
EBIT margin target set at 14%-16% for 2026–2030, reflecting investment needs for growth and M&A integration.
Sales/revenue growth target above 10% CAGR, with a focus on maintaining a strong equity-asset ratio above 30%.
Willing to temporarily exceed net debt/EBITDA target for attractive M&A opportunities, leveraging strong cash flow to deleverage post-acquisition.
No plans for share buybacks; capital allocation prioritized for M&A and dividends.
M&A and Business Development
Accelerated M&A agenda, especially in thermoplastics and TPE, with a robust pipeline and readiness to increase pace by adding resources.
Focused on bolt-on acquisitions, portfolio expansion, and entering new geographies, particularly in the US, Europe, and Asia.
Integration approach leverages best practices, people, and supplier/customer relationships from acquired companies.
Selective on acquisition targets, prioritizing strategic fit, financial performance, and cultural alignment.
Confident in ability to replicate rubber compounding roll-up success in thermoplastics, but with a segment-focused approach rather than overall market leadership.
Latest events from HEXPOL
- Q4 saw lower sales and margins from FX and mix, but volumes and cash flow improved.HPOL
Q4 20253 Feb 2026 - Sales fell but margins rose, supporting a strong outlook and continued M&A focus.HPOL
Q2 20243 Feb 2026 - Sales and profit declined 9% year-over-year, but margins and cash flow stayed strong.HPOL
Q3 202418 Jan 2026 - Sales and profit declined, but cash flow and margins remained strong amid efficiency actions.HPOL
Q4 20249 Jan 2026 - Sales up 1% and Engineered Products grew 15%, but margins pressured by product mix.HPOL
Q1 202521 Dec 2025 - Q3 sales and EBIT declined, but strong cash flow and acquisitions supported resilience.HPOL
Q3 202524 Oct 2025 - Sales and profit declined, but Engineered Products and cash flow improved.HPOL
Q2 202518 Jul 2025